macular degeneration Genosity Inks Deal With Gemini Therapeutics to Develop Assay for AMD Clinical Trial Patient Selection The assay will be used to select patients for enrollment in a Phase IIa study of Gemini Therapeutics' dry age-related macular degeneration drug GEM103. Homomorphic Encryption Might Hold Key to Fast, Large-Scale GWAS Premium Researchers from startup Duality Technologies and Dana-Farber have demonstrated the efficacy and speed of a highly secure technique for analyzing encrypted genomic data. Age-Related Macular Degeneration Genes Revealed in Transcriptome Studies A team led by National Eye Institute researchers picked out B3GLCT and BLOC1S1 as the most plausible target genes in an age-related macular degeneration analysis. Inherited Retinal Disease Patients, Therapy Developers May Benefit From New Genetic Testing Program Premium To study the benefit of genetic testing data, the Foundation Fighting Blindness offered free clinical testing to 100 members of its My Retina Tracker patient registry. International Consortium IDs New Loci Linked to Age-Related Macular Degeneration The International AMD Genomics Consortium has uncovered 34 AMD-associated loci, including a site with specific ties to the wet AMD subtype. Sep 16, 2015 Studies Confirm Interaction of Genetics, Diet, Exercise Affect Age-Related Macular Degeneration Risk Nov 26, 2014 OliX Licenses AMD Drug to YuYu Pharma Premium Nov 25, 2014 Benitec Provides Update on HCV, Earlier-stage Pipeline Programs Premium Oct 27, 2014 NEI Awards Cellular Dynamics $1.2M Contract for iPSCs for Development of AMD Drug Jul 7, 2014 AMD Insight Licenses ArcticDx's Age-related Macular Degeneration MDx Test Jan 16, 2014 Nicox to Market Sequenom's RetnaGene AMD Test in North America Oct 24, 2013 Scripps Team Shows Potential of microRNA Knockdown for Ocular Diseases Premium Sep 16, 2013 Rare Variant Studies Underscore Immune Pathway Role in Age-related Macular Degeneration Jul 18, 2013 RXi Releases Phase I Data on Anti-Scarring Drug, Aims for Phase II This Year Premium Jun 13, 2013 After Acquiring Opko Assets, RXi Aims to Resurrect Former Phase III AMD Drug Premium Apr 4, 2013 Washington University Team Reports on Link Between microRNA-33 and AMD Premium Mar 4, 2013 GWAS Meta-analysis Reveals 19 Loci Linked to Age-related Macular Degeneration Risk Nov 9, 2012 Sequenom, ArcticDx Settle IP Litigation Mar 22, 2012 Silence Says Cash Runway Ends in Q3, Directors Have 'Uncertainty' About Additional Fundraising Premium Mar 1, 2012 Canadian MDx Firm ArcticDx Takes Sequenom to Court over Patent Fight May 17, 2011 Renaming its Genome Center, Wash U Expands Focus to Clinical Applications of Sequencing Premium Mar 24, 2011 Quark, Pfizer Amend Deal for Ocular Disease Drug on Less-than-Ideal Phase II Data Premium Feb 10, 2011 Q&A: Univeristy of Kentucky's Jayakrishna Ambati on a Role for Dicer in AMD Premium Nov 12, 2010 ArcticDx Comes to US, Eyes FDA Approval for AMD Test Feb 9, 2010 Sequenom Licenses Rights to Macular Degeneration Genetic Test Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.